FDA
-
-
-
-
-
-
-
AC Immune SA (ACIU) Reports Positive Interim Results from Phase 2 Trial of ACI-7104.056
-
-
-
-
-
-
-
AC Immune's (ACIU) ACI-35.030 Granted FDA Fast Track Designation for Alzheimer’s Disease
-
-
-
-
-
-
-
AC Immune SA (ACIU) Receives FDA Fast Track Designation for ACI-24.060
-
-
-
-
-
-
-
AC Immune Announces New Clinical Results in Down Syndrome and Plans for Future Development of Anti-Amyloid-Beta Vaccine
-
-
-
-
-
329,986 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

